India's medical technology sector is projected to reach a $35 billion market size by 2030, supported by medical device exports expected to hit $8 billion. This growth is driven by rising healthcare demand and a shift toward local innovation for resource-constrained markets.
The Indian medical technology industry is entering a new phase of expansion, with recent projections valuing the market at $35 billion by 2030. This growth is fueled by a strong push in both domestic manufacturing and export capabilities. Data from the fiscal year 2025 shows medical device exports stood at $4 billion, a figure that is expected to double to $8 billion over the next five years. This shift reflects India's transition from being a simple manufacturing base to an innovation-driven healthcare hub.
Scaling Healthcare Demand and Innovation
India's overall healthcare demand is set to climb, with expectations that it will exceed $320 billion as the sector grows at an annual rate of 10-12 percent. This rising domestic need provides a steady foundation for medtech companies to scale their operations. A key strength highlighted in recent industry analysis is India's role as an 'access-led innovator.' This means domestic companies are effectively designing medical devices that function well in environments with limited infrastructure and cost constraints—a model that is increasingly relevant not just in India, but in various global markets facing similar pressures.
Navigating the Asia-Pacific Medtech Landscape
In the broader Asia-Pacific region, the demand for medical technology is forecast to reach $132 billion by 2030, growing faster than the global market average. While India is gaining momentum, it faces a complex landscape. Currently, India imports a significant volume of medical devices, with imports totaling $5.5 billion in fiscal year 2025. This high import dependency points to a clear opportunity for local players to capture market share by developing high-end devices that were previously sourced from abroad.
Strategic Challenges for Domestic Players
While the growth outlook is positive, the industry’s success depends on several operational factors. Moving up the value chain requires companies to go beyond basic manufacturing. The key monitorables for investors include the ability of Indian firms to strengthen clinical evidence, navigate evolving regulatory frameworks, and execute effective commercialization strategies. Additionally, the sector faces competition from other regional hubs like South Korea, which has established a strong presence in software-focused medical innovation. Future performance will largely depend on how effectively domestic companies can balance the cost-efficiency required for local markets with the high-tech standards needed to compete internationally.